StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3046% below fair value
$83.48−0.91 (-1.08%)

Close on Nov 17, 2026Market cap $34.50BP/E 13.7Yield 2.43%

Zoetis r&d expenses

Research and development expenses are spending on new products and technology.

Zoetis's R&D Expenses for the twelve months ending Jun 30, 2026 was $722.00M, up 6.0% year over year. For fiscal 2025 it was $698.00M, up 1.7% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $698.00M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$698.00M+1.7%
FY2024Dec 31, 2024$686.00M+11.7%
FY2023Dec 31, 2023$614.00M+13.9%
FY2022Dec 31, 2022$539.00M+6.1%
FY2021Dec 31, 2021$508.00M+9.7%
FY2020Dec 31, 2020$463.00M+1.3%
FY2019Dec 31, 2019$457.00M+5.8%
FY2018Dec 31, 2018$432.00M+13.1%
FY2017Dec 31, 2017$382.00M+1.6%
FY2016Dec 31, 2016$376.00M+3.3%
FY2015Dec 31, 2015$364.00M-8.1%
FY2014Dec 31, 2014$396.00M-0.8%
FY2013Dec 31, 2013$399.00M-2.4%
FY2012Dec 31, 2012$409.00M-4.2%
FY2011Dec 31, 2011$427.00M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$173.00M+4.2%
Q1 FY2026Mar 31, 2026$180.00M+11.1%
Q4 FY2025Dec 31, 2025$199.00M+7.0%
Q3 FY2025Sep 30, 2025$170.00M+1.8%
Q2 FY2025Jun 30, 2025$166.00M-2.9%
Q1 FY2025Mar 31, 2025$162.00M0.0%
Q4 FY2024Dec 31, 2024$186.00M+6.9%
Q3 FY2024Sep 30, 2024$167.00M+9.9%
Q2 FY2024Jun 30, 2024$171.00M+17.1%
Q1 FY2024Mar 31, 2024$162.00M+14.1%
Q4 FY2023Dec 31, 2023$174.00M+17.6%
Q3 FY2023Sep 30, 2023$152.00M+13.4%
Q2 FY2023Jun 30, 2023$146.00M+8.1%
Q1 FY2023Mar 31, 2023$142.00M+16.4%
Q4 FY2022Dec 31, 2022$148.00M+7.2%
Q3 FY2022Sep 30, 2022$134.00M+1.5%
Q2 FY2022Jun 30, 2022$135.00M+12.5%
Q1 FY2022Mar 31, 2022$122.00M+3.4%
Q4 FY2021Dec 31, 2021$138.00M+3.8%
Q3 FY2021Sep 30, 2021$132.00M+17.9%
Q2 FY2021Jun 30, 2021$120.00M+8.1%
Q1 FY2021Mar 31, 2021$118.00M+10.3%
Q4 FY2020Dec 31, 2020$133.00M+0.8%
Q3 FY2020Sep 30, 2020$112.00M0.0%
Q2 FY2020Jun 30, 2020$111.00M0.0%
Q1 FY2020Mar 31, 2020$107.00M+4.9%
Q4 FY2019Dec 31, 2019$132.00M+5.6%
Q3 FY2019Sep 30, 2019$112.00M+3.7%
Q2 FY2019Jun 30, 2019$111.00M+8.8%
Q1 FY2019Mar 31, 2019$102.00M+5.2%
Q4 FY2018Dec 31, 2018$125.00M+13.6%
Q3 FY2018Sep 30, 2018$108.00M+12.5%
Q2 FY2018Jun 30, 2018$102.00M+18.6%
Q1 FY2018Mar 31, 2018$97.00M+7.8%
Q4 FY2017Dec 31, 2017$110.00M+1.9%
Q3 FY2017Oct 1, 2017$96.00M+6.7%
Q2 FY2017Jul 2, 2017$86.00M–
Q1 FY2017Apr 2, 2017$90.00M–
Q4 FY2016Dec 31, 2016$108.00M–
Q3 FY2016Oct 2, 2016$90.00M–

More Zoetis figures

See a number that looks wrong?